A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

Clinical trial NCT03329092 · COMPLETED

Trial details

NCT number: NCT03329092
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Complicated Intra-abdominal Infection Hosptial Acquired Pneumonia Ventilator Associated Pneumonia

Start date: 2018-04-05
Primary completion: 2023-02-23
Enrollment: 422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.